Suchergebnisse - "Frisell, Thomas"

PubPharm (32)

1

Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs : Results from a 10-year international post-marketing study

enthalten in: Seminars in arthritis and rheumatism | 2024

von Simon, T. | Suissa, S. | Boers, M. | +10

2

Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs : Results from a 10-year international post-marketing study

enthalten in: Seminars in arthritis and rheumatism | 2024

von Simon, T. | Suissa, S. | Skovron, M. | +11

3

Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis : a comprehensive evaluation of randomised controlled trials and observational studies

enthalten in: Annals of the rheumatic diseases | 2024

von Simon, T. | Dong, L. | Suissa, S. | +11

4

Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice : an observational cohort study from Sweden in patients with rheumatoid arthritis

enthalten in: RMD open | 2023

von Bower, H. | Frisell, T. | di Giuseppe, D. | +2

5

Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis : a marginal structural model application

enthalten in: Rheumatology (Oxford, England) | 2023

von Barbulescu, A. | Sjölander, A. | Delcoigne, B. | +2

6

Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis : a national real-world cohort study

enthalten in: Annals of the rheumatic diseases | 2023

von Huss, V. | Bower, H. | Hellgren, K. | +16

CommentIn: Ann Intern Med. 2023 Jul;176(7):JC83. - PMID 37399557

7

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice : results from the ARTIS programme

enthalten in: Annals of the rheumatic diseases | 2023

von Frisell, T. | Bower, H. | Morin, M. | +21

8

Temporal trends in adverse pregnancy outcomes in axial spondyloarthritis in Sweden : a cohort study

enthalten in: The Lancet. Rheumatology | 2023

von Morin, M. | Frisell, T. | Stephansson, O. | +1

9

Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs : a Swedish comparative safety study among patients with rheumatoid arthritis

enthalten in: Annals of the rheumatic diseases | 2023

von Molander, V. | Bower, H. | Frisell, T. | +18

10

Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration

enthalten in: Rheumatology (Oxford, England) | 2022

von Delcoigne, B. | Provan, S. | Hammer, H. | +10

ErratumIn: Rheumatology (Oxford). 2022 Mar 25;:. - PMID 35333334